Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2001

View Archived Issues

Peptides that stabilize protein antigens available for licensing from NIH

Corixa and Nycomed Amersham Imaging to copromote Metastron

PTC Therapeutics awarded SBIR grant to support HIV research

New pseudomycin prodrugs with superior therapeutic index

Positive phase II results for NBI-34060 in subjects with chronic insomnia

Major European launch for single-bolus thrombolytic

Discovery of novel classes of CFTR activators revealed by U. of California team

Novartis discovers potential new class of antidiabetic agents

Synthetic low-molecular-weight thrombin inhibitor and oral prodrug profiled at ISTH meeting

BTG commences phase I clinical trial of new anticancer agent

Nanogen Recognomics created from Nanogen-Aventis R&T collaboration

Inhibitor of vWF-collagen interaction effective in primate model of thrombosis

Ortec's wound-healing product to be marketed as OrCel; FDA advisory panel recommends approval

Antibody to high-molecular-weight kininogen effectively inhibits angiogenesis in tumor models

TransCell system demonstrates oral absorption in initial exploratory studies

Solvay advances cilansetron to phase III for IBS

Signature BioScience acquires Cambridge Discovery Chemistry from Millennium

Shorter treatment regimen for Valtrex approved by FDA

Baxter receives EMEA approval for Ceprotin

Promising preclinical antiangiogenic, antitumor activity described for PKCbeta inhibitor

Bristol-Myers Squibb and Exelixis focus on tumor suppressor genes

XTL and Dong Wha enter hepatitis C alliance

Therapy of psoriasis with anti-TNF-alpha antibodies

Antibacterial agents with additional pharmacological properties developed at Antex Pharma

2-Arylquinolines selectively relax urethral smooth muscle according to recent patent

Hormos presents new series of SERMs and their potential uses

Opioid receptor ligands designed by Palatin

Antiproliferative vitamin D analogues from Galderma particularly useful in dermatology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...